The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Neurofibromatosis 2 (NF2): Clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity
Abstract
To determine the spectrum of manifestations in neurofibromatosis 2 (NF2) and to assess possible heterogeneity, we evaluated 63 affected individuals from 32 families. Work‐up included skin and neurologic examinations, audiometry, a complete ophthalmology examination with slit‐lamp biomicroscopy of the lens and fundus, and gadolinium‐enhanced MRI of the brain and, in some, of the spine. Mean age‐at‐onset in 58 individuals was 20.3 years; initial symptoms resulted from vestibular schwannomas (44.4%), other CNS tumors (22.2%), skin tumors (12.7%), and ocular manifestations including cataracts and retinal hamartomas (12.7%). Five asymptomatic individuals were diagnosed through screening. Vestibular schwannomas were documented in 62 individuals (98.4%); other findings included cataracts (81.0%), skin tumors (67.7%), spinal tumors (67.4%), and meningiomas (49.2%). Usually, clinical manifestations and course were similar within families but differed among families. To assess possible heterogeneity, we assigned affected individuals to three proposed subtypes (representing mild, intermediate, and severe NF2) based on age‐at‐onset, presence or absence of CNS tumors other than vestibular schwannomas, and presence or absence of retinal hamartomas. Comparisons among the three subtypes for many clinical parameters demonstrated that patients in the mild subtype differed from those in the other two subtypes for most parameters, but that none of the parameters distinguished patients in the intermediate subtype from those in the severe subtype. Thus, there are likely two rather than three subtypes of NF2. Classification of patients to subtype may aid in counseling about long‐term prognosis and in formulating individualized guidelines for medical surveillance. © 1994 Wiley‐Liss, Inc.This article is a U.S. Government work and, as such, is in the public domain in the United States of America .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurofibromatosis: Conference Statement
(1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520290115023 · Cited by 1,547
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J., Mitchell, A. L., et al. (1990) · Science · doi:10.1126/science.2134734 · Cited by 1,475
Rouleau, G. A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., Hoang-Xuan, K., Demczuk, S., Desmaze, C., Plougastel, B., et al. (1993) · Nature · doi:10.1038/363515a0 · Cited by 1,420
Self-citationTrofatter, J. (1993) · Cell · doi:10.1016/0092-8674(93)90406-g · Cited by 1,403
Von Recklinghausen Neurofibromatosis
Riccardi, V. M. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112313052704 · Cited by 1,344
Neurofibromatosis. Conference statement, National Institute of Health development conference
Stumpf, D. A. (1988) · JAMA Neurology · Cited by 1,236
Cawthon, R. M., Weiss, R., Xu, G., Viskochil, D., Culver, M., Stevens, J., Robertson, M., Dunn, D., Gesteland, R., O'Connell, P., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90253-b · Cited by 1,094
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
Viskochil, D., Buchberg, A. M., Xu, G., Cawthon, R. M., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90252-a · Cited by 1,082
VON RECKLINGHAUSEN NEUROFIBROMATOSIS: A CLINICAL AND POPULATION STUDY IN SOUTH-EAST WALES
HUSON, S. M., HARPER, P. S., & COMPSTON, D. A. S. (1988) · Brain · doi:10.1093/brain/111.6.1355 · Cited by 686
A Clinical Study of Type 2 Neurofibromatosis
(1992) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068699 · Cited by 634
Long-Term Follow-up of von Recklinghausen Neurofibromatosis
Sørensen, S. A., Mulvihill, J. J., & Nielsen, A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604173141603 · Cited by 617
Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma
Seizinger, B. R., Martuza, R. L., & Gusella, J. F. (1986) · Nature · doi:10.1038/322644a0 · Cited by 524
Evans, D. G., Huson, S. M., Donnai, D., Neary, W., Blair, V, Teare, D., Newton, V, Strachan, T., Ramsden, R., & Harris, R. (1992) · Journal of Medical Genetics · doi:10.1136/jmg.29.12.841 · Cited by 468
Principles and Practice of Ophthalmology
Mannis, M. J. (1994) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)73166-6 · Cited by 418
Common Pathogenetic Mechanism for Three Tumor Types in Bilateral Acoustic Neurofibromatosis
Seizinger, B. R., Rouleau, G. A., Ozelius, L. J., et al. (1987) · Science · doi:10.1126/science.3105060 · Cited by 256
Halliday, A. L., Sobel, R. A., & Martuza, R. L. (1991) · Journal of neurosurgery · doi:10.3171/jns.1991.74.2.0248 · Cited by 158
Loss of constitutional heterozygosity in colon carcinoma from patients with familial polyposis coli
Okamoto, M., Sasaki, M., Sugio, K., Sato, C., Iwama∥, T., Ikeuchi, T., Tonomura, A., Sasazuki, T., & Miyaki, M. (1988) · Nature · doi:10.1038/331273a0 · Cited by 156
Amiodarone-Induced Gynecomastia
Pearson-Webb, M. A., Kaiser‐Kupfer, M. I., & Eldridge, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612113152419 · Cited by 65
Self-citationLens opacities in neurofibromatosis 2: further significant correlations.
Bouzas, E. A., Freidlin, V., Parry, D. M., Eldridge, R., & Kaiser‐Kupfer, M. I. (1993) · British Journal of Ophthalmology · doi:10.1136/bjo.77.6.354 · Cited by 56
Self-citationSivalingam, A., Augsburger, J. J., Perilongo, G., Zimmerman, R., & Barabas, G. (1991) · Journal of Pediatric Ophthalmology & Strabismus · doi:10.3928/0191-3913-19911101-08 · Cited by 46
Thomas, P. K., King, R. H. M., Chiang, T. R., Scaravilli, F., Sharma, A. K., & Downie, A. W. (1990) · Muscle & Nerve · doi:10.1002/mus.880130202 · Cited by 45
A case of neurofibromatosis 2 presenting with a mononeuritis multiplex.
Kilpatrick, T. J., Hjorth, R., & Gonzales, M. F. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.5.391 · Cited by 18
Cited by
Gutmann, D. H. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550010065042 · Cited by 1,359
Asthagiri, A. R., Parry, D. M., Butman, J. A., Kim, H. J., Tsilou, E. T., Zhuang, Z., & Lonser, R. R. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60259-2 · Cited by 665
Self-citationThe clinical and diagnostic implications mosaicism in the neurofibromatoses
Ruggieri, M., & Huson, S. M. (2001) · Neurology · doi:10.1212/wnl.56.11.1433 · Cited by 387
Antinheimo, J., Sankila, R., Carpén, O., Pukkala, E., Sainio, M., & Jääskeläinen, J. (2000) · Neurology · doi:10.1212/wnl.54.1.71 · Cited by 338
Schwannomas and Their Pathogenesis
Hilton, D. A., & Hanemann, C. O. (2014) · Brain Pathology · doi:10.1111/bpa.12125 · Cited by 309
Metadata
- Authors
- Parry, D. M., Eldridge, R., Kaiser‐Kupfer, M. I., Bouzas, E. A., Pikus, A., & Patronas, N.
- Venue
- American Journal of Medical Genetics
- Publisher
- Wiley
- Published
- 1994-10
- Volume
- 52
- Issue
- 4
- Pages
- 450-461
- ISSN
- 0148-7299 (ISSN-L)
- 1096-8628
- OpenAlex
- W2035781246
- Cited by
- 421
- References
- 22
- FWCI
- 8.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.